Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease

ConclusionIP chemotherapy has a clear role in the management of patients with GCPC, and when combined with CRS in appropriately selected patients has the potential to significantly improve survival. Ongoing and upcoming IP therapy clinical trials hold great promise to shape the treatment paradigm for GCPC.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research